Abstract
The aim of this study was to develop a delivery system to enable the promotion of the antitumor potential of fucoidan (FUC). FUC/N-trimethylchitosan (TMC) ion-complex submicron particles (FUC/TMC-SMP) were produced by ionic complexation, and their particle characteristics were investigated. Antitumor effect was examined in vivo using sarcoma 180-bearing mice by oral administration, and body weight loss was checked as an index of toxic side effects. FUC/TMC-SMP could be obtained by the complexation of negatively charged fucoidan with positively charged N-trimethylchitosan under aqueous conditions. The mean particle size was 325 nm and mean FUC content was 47 % (w/w). Oral administration was conducted using two treatment schedules, that is, pre- and post-tumor inoculation. As to pre-treatment, oral administration was performed from 13 days before inoculation to 1 day before inoculation every other day. For post-treatment, preparation samples were administered orally from 1 day after inoculation to 13 days after inoculation every other day. FUC/TMC-SMP were more effective than FUC solution and suppressed tumor growth significantly in both treatment schedules. FUC/TMC-SMP are suggested to be a useful oral delivery system enhancing the antitumor potential of FUC.
Keywords: Ion-complex submicron particles, fucoidan, N-trimethylchitosan, antitumor effect, oral administration, treatment schedule, Submicron particles, Ionic complexation, Particle characteristics, Pre-treatment, Post-treatment, Sarcoma 180, Toxic side effect
Current Nanoscience
Title: Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles
Volume: 7 Issue: 4
Author(s): Kazuya Hayashi, Masanaho Sasatsu, Yoshiharu Machida and Hiraku Onishi
Affiliation:
Keywords: Ion-complex submicron particles, fucoidan, N-trimethylchitosan, antitumor effect, oral administration, treatment schedule, Submicron particles, Ionic complexation, Particle characteristics, Pre-treatment, Post-treatment, Sarcoma 180, Toxic side effect
Abstract: The aim of this study was to develop a delivery system to enable the promotion of the antitumor potential of fucoidan (FUC). FUC/N-trimethylchitosan (TMC) ion-complex submicron particles (FUC/TMC-SMP) were produced by ionic complexation, and their particle characteristics were investigated. Antitumor effect was examined in vivo using sarcoma 180-bearing mice by oral administration, and body weight loss was checked as an index of toxic side effects. FUC/TMC-SMP could be obtained by the complexation of negatively charged fucoidan with positively charged N-trimethylchitosan under aqueous conditions. The mean particle size was 325 nm and mean FUC content was 47 % (w/w). Oral administration was conducted using two treatment schedules, that is, pre- and post-tumor inoculation. As to pre-treatment, oral administration was performed from 13 days before inoculation to 1 day before inoculation every other day. For post-treatment, preparation samples were administered orally from 1 day after inoculation to 13 days after inoculation every other day. FUC/TMC-SMP were more effective than FUC solution and suppressed tumor growth significantly in both treatment schedules. FUC/TMC-SMP are suggested to be a useful oral delivery system enhancing the antitumor potential of FUC.
Export Options
About this article
Cite this article as:
Hayashi Kazuya, Sasatsu Masanaho, Machida Yoshiharu and Onishi Hiraku, Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles, Current Nanoscience 2011; 7 (4) . https://dx.doi.org/10.2174/157341311796196862
DOI https://dx.doi.org/10.2174/157341311796196862 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia
Current Cancer Drug Targets Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
Reviews on Recent Clinical Trials Patenting Networking and Knowledge Translation in Liposomes for Cancer Therapy
Recent Patents on Nanomedicine Long-term Exposure to Cadmium in Food and Cigarette Smoke, Liver Effects and Hepatocellular Carcinoma
Current Drug Metabolism Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets New Perspectives of HIV/AIDS Therapy Study
Recent Patents on Anti-Infective Drug Discovery Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers
Current Hypertension Reviews The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Investigations of Malignant Mesothelioma
Current Respiratory Medicine Reviews Recent Progress on Tumor Missile Therapy and Tumor Vascular Targeting Therapy as a New Approach
Current Vascular Pharmacology Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Current Cancer Drug Targets The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design The Use of Interferons in Respiratory Diseases
Current Respiratory Medicine Reviews Regulation of Runx2 and Its Signaling Pathways by MicroRNAs in Breast Cancer Metastasis
Current Protein & Peptide Science Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design